News

September 29, 2009 – Cordis Corp. and Boston Scientific announced late today they reached an agreement to resolve several pending lawsuits over intellectual property related to drug-eluting stent and balloon deliver system technologies.

Home September 29, 2009
Home
News

September 29, 2009 – Abiomed Inc. announced new clinical data last week at TCT 2009 from Academic Medical Center’s (AMC) three-year follow-up results from patients in the Impella 2.5 arm of the MACH II trial, revealing improved left ventricular function, cardiac output and quality of life.

Home September 29, 2009
Home
News

September 29, 2009 – Volcano Corp.

Home September 29, 2009
Home
News

September 29, 2009 – Mardil Inc. last week at TCT 2009 announced positive interim data from a pilot study investigating the safety and efficacy of its novel cardiac device – BACE (Basal Annuloplasty of the Cardia Externally) – in treating mitral valve regurgitation.

Home September 29, 2009
Home
News

September 29, 2009 – Elixir Medical Corp. last week at TCT 2009 announced positive results from three multicenter first-in-man studies of its novolimus and myolimus-eluting coronary stent systems with durable and bioabsorbable polymers. Novolimus-Eluting Coronary Stent System With Bioabsorbable Polymer

Home September 29, 2009
Home
News

September 29, 2009 – Boston Scientific Corp. Sept. 25 announced two-year follow-up data from the HORIZONS-AMI trial, is designed to determine the safety and efficacy of the TAXUS Express2 Paclitaxel-Eluting Coronary Stent System compared to bare-metal stenting in patients experiencing an acute myocardial infarction (AMI).

Home September 29, 2009
Home
News

September 29, 2009 – At six months, patients receiving the NEVO Sirolimus-Eluting Coronary Stent reported significantly less chest pain than those receiving the TAXUS Liberte stent, and patients also reported improvements in their overall quality of life.

Home September 29, 2009
Home
News

September 29, 2009 – The United States Court of Appeals for the Federal Circuit last week affirmed the previous ruling of the United States District Court for the Northern District of California that Cook Incorporated does not infringe on Edwards’ patents for endovascular devices to treat aneurysms, Cook officials said.

Home September 29, 2009
Home
News

September 29, 2009 – GE Healthcare said the first clinical use of true integrated Fractional Flow Reserve (FFR) has been implemented at Christus St. Vincent Regional Medical Center in Santa Fe, N.M., to evaluate the severity of lesions in coronary arteries.

Home September 29, 2009
Home
News

September 28, 2009 – New data from the phase III PLATO study showed that ticagrelor (BRILINTA) provided 16 percent reduction of cardiovascular (CV) events (composite of CV death, heart attack and stroke) than clopidogrel (9.02 vs. 10.65 percent) in acute coronary syndromes patients undergoing planned invasive treatment of either PCI or CABG.

Home September 29, 2009
Home
News

September 28, 2009 – Sanofi-aventis announced last week the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has adopted a positive opinion recommending to grant a marketing authorization in the European Union for Multaq (dronedarone 400mg tablets).

Home September 29, 2009
Home
News

September 28, 2009 – Data supporting the long-term safety and effectiveness of renal sympathetic denervation (RDN) using radio-frequency ablation in treating patients with chronic hypertension were presented Sept. 25 at the Transcatheter Cardiovascular Therapeutics (TCT) conference in San Francisco.

Home September 29, 2009
Home
News

September 29, 2009 - Positron Corp., a molecular imaging solutions company focused on nuclear cardiology, will attend the 14th Annual American Society of Nuclear Cardiology (ASNC) annual conference in Minneapolis, Minn. Oct. 1-4, to showcase their newly developed cardiac optimized PET scanner, the Attrius.

Home September 29, 2009
Home
News

September 28, 2009 - GE Healthcare and Biosense Webster Inc. announced new versions of the Vivid i and Vivid q cardiovascular ultrasound systems, with support for two new intracardiac echo (ICE) catheters.

Home September 28, 2009
Home
News

September 28, 2009 - The Agency for Healthcare Research and Quality plans to provide $100 million in stimulus funding in the coming fiscal year to support studies of the effectiveness of treatments and diagnostics, including personalized healthcare approaches, such as pharmacogenetics, clinical diagnostics, and bio-imaging studies.

Home September 28, 2009
Home
Subscribe Now